Sara Zaknoen
Direktor/Vorstandsmitglied bei ATYR PHARMA, INC.
Vermögen: 9 570 $ am 30.04.2024
Profil
Dr. Sara L.
Zaknoen, MD, is an Independent Director at aTyr Pharma, Inc. She is on the Board of Directors at aTyr Pharma, Inc. Dr. Zaknoen was previously employed as a Chief Medical Officer by Ignyta, Inc., a Chief Medical Officer by Tragara Pharmaceuticals, Inc., a Director-Clinical Oncology Research by Schering-Plough Research Institute, a Chief Medical Officer by Cabrellis Pharmaceuticals Corp., an Executive Director-Clinical Oncology Research by Novartis Pharmaceuticals Corp., a Chief Medical Officer by Polynoma LLC, a Director-Experimental Therapeutics by The Western Pennsylvania Hospital, and a Medical Director by University of Cincinnati (Ohio).
She received her undergraduate degree from Valparaiso University and a doctorate degree from Indiana University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ATYR PHARMA, INC.
0,01% | 01.03.2024 | 6 000 ( 0,01% ) | 9 570 $ | 30.04.2024 |
Aktive Positionen von Sara Zaknoen
| Unternehmen | Position | Beginn |
|---|---|---|
| ATYR PHARMA, INC. | Direktor/Vorstandsmitglied | 25.05.2021 |
Ehemalige bekannte Positionen von Sara Zaknoen
| Unternehmen | Position | Ende |
|---|---|---|
| IGNYTA INC | Technik-/Wissenschafts-/F&E-Leiter | 28.04.2014 |
Adastra Pharmaceuticals, Inc.
 Adastra Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Adastra Pharmaceuticals, Inc. engages in the provision of clinical and commercial development of proprietary drugs for the treatment of various cancers. The company was founded by Tracy L. Parrott in 2005 and is headquartered in Princeton, NJ. | Technik-/Wissenschafts-/F&E-Leiter | - |
Cabrellis Pharmaceuticals Corp.
 Cabrellis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Cabrellis Pharmaceuticals Corp. manufactures medical products. The firm develops therapies for treatment of cancer. The company was founded by Thomas M. Estok, Lawrence C. Fritz and Christopher C. LeMasters in 2006 and is headquartered in Summit, NJ. | Technik-/Wissenschafts-/F&E-Leiter | - |
Schering-Plough Research Institute
 Schering-Plough Research Institute Medical SpecialtiesHealth Technology Schering-Plough Research Institute provides pharmaceutical research. The company is headquartered in Kenilworth, NJ. | Corporate Officer/Principal | 02.01.2002 |
Polynoma LLC
 Polynoma LLC BiotechnologyHealth Technology Part of CK Life Sciences International (Holdings), Inc., Polynoma LLC is an immuno-oncology focused biopharmaceutical company headquartered in San Diego, CA. Polynoma's lead asset is a novel polyvalent antigen vaccine, Seviprotimut-L, for the prevention of recurrence of melanoma. The vaccine has been safely administered in more than 1,000 patients. Polynoma is an immuno-oncology company developing a novel polyvalent antigen therapy for the treatment of melanoma. The company was founded by Paul A. Hopper. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Sara Zaknoen
| Indiana University | Doctorate Degree |
| Valparaiso University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ATYR PHARMA, INC. | Health Technology |
| Private Unternehmen | 7 |
|---|---|
Adastra Pharmaceuticals, Inc.
Adastra Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Adastra Pharmaceuticals, Inc. engages in the provision of clinical and commercial development of proprietary drugs for the treatment of various cancers. The company was founded by Tracy L. Parrott in 2005 and is headquartered in Princeton, NJ. | Health Technology |
Cabrellis Pharmaceuticals Corp.
Cabrellis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Cabrellis Pharmaceuticals Corp. manufactures medical products. The firm develops therapies for treatment of cancer. The company was founded by Thomas M. Estok, Lawrence C. Fritz and Christopher C. LeMasters in 2006 and is headquartered in Summit, NJ. | Health Technology |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Health Technology |
Schering-Plough Research Institute
Schering-Plough Research Institute Medical SpecialtiesHealth Technology Schering-Plough Research Institute provides pharmaceutical research. The company is headquartered in Kenilworth, NJ. | Health Technology |
The Western Pennsylvania Hospital
 The Western Pennsylvania Hospital Medical/Nursing ServicesHealth Services The Western Pennsylvania Hospital provides clinical and health related services. The hospital offers emergency medicine, heart care, cancer treatment, orthopedics, and surgery services. It is affiliated with Clarion University, Indiana University of Pennsylvania, Pennsylvania State University, and Temple University. The Western Pennsylvania Hospital is founded in 1848 and is headquartered in Pittsburgh, PA. | Health Services |
Ignyta, Inc.
 Ignyta, Inc. BiotechnologyHealth Technology Ignyta, Inc. operates as a medicine biotechnology company. The firm engages in the discovering, acquiring, developing and commercializing targeted new drugs for cancer patients. The company was founded by Jonathan E. Lim on September 13, 2011 and is headquartered in South San Francisco, CA. | Health Technology |
Polynoma LLC
Polynoma LLC BiotechnologyHealth Technology Part of CK Life Sciences International (Holdings), Inc., Polynoma LLC is an immuno-oncology focused biopharmaceutical company headquartered in San Diego, CA. Polynoma's lead asset is a novel polyvalent antigen vaccine, Seviprotimut-L, for the prevention of recurrence of melanoma. The vaccine has been safely administered in more than 1,000 patients. Polynoma is an immuno-oncology company developing a novel polyvalent antigen therapy for the treatment of melanoma. The company was founded by Paul A. Hopper. | Health Technology |
